Vimta Labs Q4 Results
- BSE: 524394
- NSE: VIMTALABS
- ISIN: INE579C01029
- Sector: Biotechnology & Drugs
BSE
435.00
-4.05 (-0.92%)
-4.05 (-0.92%)Volume4.35 K
Updated: Fri 6 Mar, 2026 | 15:28:00
NSE
432-7.00 (-1.59%)
-7.00 (-1.59%)Volume1.07 L
Updated: Fri 6 Mar, 2026 | 15:25:39
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Vimta Labs Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 70.62 | 76.94 | 5.95% | 54.65 | 29.20% |
| Depreciation/ Amortization | 9.21 | 10.92 | -6.07% | 7.84 | 17.56% |
| Operating Income | 23.83 | 21.70 | 2.36% | 18.08 | 31.79% |
| Net Income | 18.32 | 17.59 | -14.77% | 12.35 | 48.32% |
| Other Operating Expenses Total | 12.78 | 16.63 | -0.49% | 8.36 | 52.82% |
| Net Income Before Taxes | 25.03 | 23.37 | 4.65% | 17.94 | 39.54% |
| Total Revenue | 94.44 | 98.63 | 5.02% | 72.73 | 29.85% |
| Selling/ General/ Admin Expenses Total | 30.45 | 28.41 | 30.30% | 25.08 | 21.38% |
| Diluted Normalized EPS | 4.03 | 4.21 | 3.53% | 3.02 | 33.51% |